Curriculum · Public Health and Communicable Diseases
Adverse effects of antituberculous drugs
What it is
The first-line drugs are isoniazid (INH), rifampin (RMP), pyrazinamide (PZA) and ethambutol (EMB), and the initial regimen is all four together. If the isolate is fully susceptible the ethambutol can be stopped, and pyrazinamide should be given for the first 2 months; after that only isoniazid and rifampin are given for the remainder of therapy, usually another 4 months. The same course is written elsewhere as 2 months of HRZE then 4 months of HR, where H is isoniazid, R is rifampicin, Z is pyrazinamide and E is ethambutol. A second standard regimen stands beside it, 2 months of HRZE then 4 months of HRE, and it applies only in countries with high levels of isoniazid resistance in new TB patients, or where isoniazid drug susceptibility testing in new patients is not done, or results are unavailable, before the continuation phase begins. The two phases are named and held on a mnemonic: the initial phase, the first 2 months, is RIPE, and the continuation phase is the next 4 months of rifampicin and isoniazid. In latent TB the options are 6 or 9 months of isoniazid monotherapy, three months of daily isoniazid plus rifampin, or four months of daily rifampin. The course is extended for some sites: spinal and bone disease 9 months, CNS 12 months, and where the patient does not respond to treatment. Patients with meningeal tuberculosis are treated for a prolonged period, at least 12 months, with the addition of steroids. CNS TB is set out as 12 months of 2HRZE + 10HR plus prednisolone 20-40 mg o.d. weaning over 2-4 weeks.
What can go wrong
Each drug carries its own list:
- Isoniazid: polyneuropathy, and pyridoxine, vitamin B6, 10 mg/day is given to prevent it; hepatitis and hepatotoxicity; and others, which are convulsions, optic neuritis, hypersensitivity and drug interactions.
- Rifampicin: nausea, vomiting and rash; hepatitis; hypersensitivity nephritis; and flu-like symptoms, which are fever, chills and myalgias.
- Pyrazinamide: nausea, vomiting and diarrhea; hepatitis; hyperuricemia, with gout rare; and hypersensitivity rash.
- Ethambutol: hypersensitivity rash; nausea, vomiting and diarrhea; optic neuritis; hyperuricemia; and nephrotoxic.
- Streptomycin: ototoxic, and that is irreversible; and nephrotoxic.
The liver is what is followed. Baseline liver function and renal function tests are important for patients treated with standard therapy. Rifampicin may cause asymptomatic hyperbilirubinaemia, but with isoniazid and pyrazinamide it may also cause hepatitis. Mild asymptomatic increases in transaminases are common, and hepatotoxicity only occurs in 2-5%. What is then done is to stop treatment, allowing symptoms to subside and liver function tests to recover; the less hepatotoxic regimens are streptomycin, ethambutol and fluoroquinolone.
On pyridoxine two lines stand together and are not the same: it is given at 10 mg/day to prevent the polyneuropathy of isoniazid, and it is not required unless subjects are at higher risk of pyrazinamide-related peripheral neuropathy in diabetes, renal failure, HIV and alcoholics.
A second page puts the same list as a mnemonic, and it is the short way to hold which drug does what. Ethambutol is the eye drug: visual problems, for example a red-green discrimination problem, with optic neuritis and a fall in visual acuity. Isoniazid is peripheral neuritis, for which vitamin B6 is given, and hepatitis, and iron accumulating in mitochondria giving a sideroblastic anemia; INH has three letters like SLE. Rifampicin is red-orange urine and secretions with P450 induction. Pyrazinamide raises uric acid and gives gout. Streptomycin is ototoxic and gives deafness, and it is contraindicated in pregnancy. So the patient who loses red-green discrimination or visual acuity on treatment is on ethambutol, and the one who goes deaf is on streptomycin. With ethambutol the eye is watched ahead of trouble: visual acuity is checked before and during treatment.
The latent infection is where the liver decides the regimen outright. Isoniazid daily for 9 months is the treatment, with no age cut-off. The alternatives for adults are isoniazid plus rifapentine once weekly for 12 doses, that is 3 months, by DOT, or rifampin daily for 4 months. And one pair is named as NOT recommended: rifampin plus PZA, and the reason written beside it is hepatotoxicity. So of the ways of covering the latent infection, that pair is the one ruled out, and it is ruled out on the liver.